David Perrin

Dr. David Perrin


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
Ali ZarrabiAli Zarrabi
Ali Zarrabi
DPDavid Perrin
David Perrin
MKMahboubeh Kavoosi
Mahboubeh Kavoosi
MSMicah Sommer
Micah Sommer
SSSerap Sezen
Serap Sezen
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
Rhabdomyosarcoma is a rare cancer arising in skeletal muscle that typically impacts children and young adults. It is a worldwide challenge in child health as treatment outcomes for metastatic and recurrent disease still pose a major concern for both basic and clinical scientists. The treatment strategies for rhabdomyosarcoma include multi-agent chemotherapies after surgical resection with or without ionization radiotherapy. In this comprehensive review, we first provide a detailed clinical understanding of rhabdomyosarcoma including its classification and subtypes, diagnosis, and treatment strategies. Later, we focus on chemotherapy strategies for this childhood sarcoma and discuss the impact of three mechanisms that are involved in the chemotherapy response including apoptosis, macro-autophagy, and the unfolded protein response. Finally, we discuss in vivo mouse and zebrafish models and in vitro three-dimensional bioengineering models of rhabdomyosarcoma to screen future therapeutic approaches and promote muscle regeneration.

13 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Ali ZarrabiAli Zarrabi
Ali Zarrabi
DPDavid Perrin
David Perrin
MKMahboubeh Kavoosi
Mahboubeh Kavoosi
MSMicah Sommer
Micah Sommer
SSSerap Sezen
Serap Sezen
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
Rhabdomyosarcoma is a rare cancer arising in skeletal muscle that typically impacts children and young adults. It is a worldwide challenge in child health as treatment outcomes for metastatic and recurrent disease still pose a major concern for both basic and clinical scientists. The treatment strategies for rhabdomyosarcoma include multi-agent chemotherapies after surgical resection with or without ionization radiotherapy. In this comprehensive review, we first provide a detailed clinical understanding of rhabdomyosarcoma including its classification and subtypes, diagnosis, and treatment strategies. Later we focus on chemotherapy strategies for this childhood sarcoma and discuss the impact of three mechanisms that are involved in chemotherapy response including apoptosis, macro-autophagy, and the unfolded protein response. Finally, we discuss in vivo mouse and zebrafish models, and in vitro 3-dimensional bioengineering models of Rhabdomyosarcoma to screen future therapeutic approaches and promote muscle regeneration.